Corona Remedies IPO allotment due as grey market premium stays elevated

Investor focus is on Corona Remedies as the company is set to finalise IPO allotment today, following the close of bidding earlier this week. The Rs 655 crore issue, priced in the range of Rs 1,008 to Rs 1,062 per share, was open from December 8 to December 10. Post-allotment, successful applicants can expect demat credits and refunds ahead of the scheduled listing. In the grey market, the IPO is commanding a premium of about 27.8%, indicating strong listing expectations.